I think it is safe to say nothing that doesn't start with a $ sign, and I can't imagine BOT management being prepared to let it go for anything less than $2.50 - and that is just based on SB alone, not taking into account any of the pipeline. With the potential for antimicrobial, rosacea and acne sitting there in the wings, I just can't imagine BOT being prepared to sell the company for any less than $5. It'll be worth that and then some in a few short years.
BOT - Anything but charting, page-6776
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.5¢ | $1.302M | 3.974M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 713153 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 215665 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |